Urology
Volume 75, Issue 2 , Pages 387-391 , February 2010

Initial Experience of Diffusion-weighted Magnetic Resonance Imaging to Assess Therapeutic Response to Induction Chemoradiotherapy Against Muscle-invasive Bladder Cancer

  • Soichiro Yoshida

      Affiliations

    • Department of Urology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan
    • ,
  • Fumitaka Koga

      Affiliations

    • Department of Urology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan
    • Corresponding Author InformationReprint requests: Fumitaka Koga, M.D., Department of Urology, Tokyo Medical and Dental University Graduate School, 1-5-45 Yushima, Bunkyo-Ku, Tokyo 113-8519, Japan
    • ,
  • Satoru Kawakami

      Affiliations

    • Department of Urology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan
    • ,
  • Chikako Ishii

      Affiliations

    • Department of Radiology, Ochanomizu Surugadai Clinic, Tokyo, Japan
    • ,
  • Hiroshi Tanaka

      Affiliations

    • Department of Radiology, Ochanomizu Surugadai Clinic, Tokyo, Japan
    • ,
  • Noboru Numao

      Affiliations

    • Department of Urology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan
    • ,
  • Yasuyuki Sakai

      Affiliations

    • Department of Urology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan
    • ,
  • Kazutaka Saito

      Affiliations

    • Department of Urology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan
    • ,
  • Hitoshi Masuda

      Affiliations

    • Department of Urology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan
    • ,
  • Yasuhisa Fujii

      Affiliations

    • Department of Urology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan
    • ,
  • Kazunori Kihara

      Affiliations

    • Department of Urology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan

Received 7 April 2009 ,Accepted 28 June 2009.

References 

  1. Housset M, Maulard C, Chretien Y, et al. Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study. J Clin Oncol. 1993;11:2150–2157
  2. Rodel C, Weiss C, Sauer R. Trimodality treatment and selective organ preservation for bladder cancer. J Clin Oncol. 2006;24:5536–5544
  3. Shipley WU, Kaufman DS, Zehr E, et al. Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer. Urology. 2002;60:62–67discussion: 67-68
  4. Chung PW, Bristow RG, Milosevic MF, et al. Long-term outcome of radiation-based conservation therapy for invasive bladder cancer. Urol Oncol. 2007;25:303–309
  5. Tekes A, Kamel I, Imam K. Dynamic MRI of bladder cancer: evaluation of staging accuracy. Am J Roentgenol. 2005;184:121–127
  6. Saksena MA, Dahl DM, Harisinghani MG. New imaging modalities in bladder cancer. World J Urol. 2006;24:473–480
  7. Dobson MJ, Carrington BM, Collins CD, et al. The assessment of irradiated bladder carcinoma using dynamic contrast-enhanced MR imaging. Clin Radiol. 2001;56:94–99
  8. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors (European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada). J Natl Cancer Inst. 2000;92:205–216
  9. Johnson RJ, Carrington BM, Jenkins JP, et al. Accuracy in staging carcinoma of the bladder by magnetic resonance imaging. Clin Radiol. 1990;41:258–263
  10. Yoshida S, Fujii Y, Yokoyama M, et al. A case of female urethral diverticular abscess clearly depicted by diffusion-weighted MRI. Int J Urol. 2008;15:460–461
  11. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. Am J Roentgenol. 2007;188:1622–1635
  12. Yoshida S, Masuda H, Ishii C, et al. Initial experience of functional imaging of upper urinary tract neoplasm by diffusion-weighted MRI. Int J Urol. 2008;15:140–143
  13. Matsuki M, Inada Y, Tatsugami F, et al. Diffusion-weighted MR imaging for urinary bladder carcinoma: initial results. Eur Radiol. 2007;17:201–204
  14. Abou-El-Ghar ME, El-Assmy A, Refaie HF, et al. Bladder cancer: diagnosis with diffusion-weighted MR imaging in patients with gross hematuria. Radiology. 2009;251:415–421
  15. Hamstra DA, Rehemtulla A, Ross BD. Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology. J Clin Oncol. 2007;25:4104–4109
  16. Pickles MD, Gibbs P, Lowry M, et al. Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging. 2006;24:843–847
  17. Yankeelov TE, Lepage M, Chakravarthy A, et al. Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. Magn Reson Imaging. 2007;25:1–13
  18. Schubert MI, Wilke M, Muller-Weihrich S, et al. Diffusion-weighted magnetic resonance imaging of treatment-associated changes in recurrent and residual medulloblastoma: preliminary observations in three children. Acta Radiol. 2006;47:1100–1104
  19. Moffat BA, Chenevert TL, Lawrence TS, et al. Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci USA. 2005;102:5524–5529
  20. Hamstra DA, Chenevert TL, Moffat BA, et al. Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc Natl Acad Sci USA. 2005;102:16759–16764
  21. Hein PA, Kremser C, Judmaier W, et al. Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study. Eur Radiol. 2003;45:214–222
  22. Dzik-Jurasz A, Domenig C, George M, et al. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet. 2002;360:307–308
  23. Kremser C, Judmaier W, Hein P, et al. Preliminary results on the influence of chemoradiation on apparent diffusion coefficients of primary rectal carcinoma measured by magnetic resonance imaging. Strahlenther Onkol. 2003;179:641–649
  24. Koga F, Yoshida S, Kawakami S, et al. Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis. Urology. 2008;72:384–388
  25. Koga F, Kihara K, Fujii Y, et al. Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low-dose chemo-radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single-institutional retrospective comparative study. BJU Int. 2009;104:189–194
  26. Kageyama Y, Okada Y, Arai G, et al. Preoperative concurrent chemoradiotherapy against muscle-invasive bladder cancer: results of partial cystectomy in elderly or high-risk patients. Jpn J Clin Oncol. 2000;30:553–556
  27. Sobin LH, Wittekind Ch. TNM Classification of Malignant Tumours. 6th ed.. New York: Wiley-Liss; 2002;
  28. Zietman AL, Grocela J, Zehr E, et al. Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder. Urology. 2001;58:380–385
  29. Herr HW. Transurethral resection of muscle-invasive bladder cancer: 10-year outcome. J Clin Oncol. 2001;19:89–93

PII: S0090-4295(09)02510-2

doi: 10.1016/j.urology.2009.06.111

Urology
Volume 75, Issue 2 , Pages 387-391 , February 2010

Article Tools

* Image Usage & Resolution